Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IV

Completed · Not applicable

Conditions studied: Mild Cognitive Impairment

In brief

This study is intended to examine the impact of receiving a genetic risk assessment for Alzheimer's disease (AD) among individuals with Mild Cognitive Impairment (MCI).

Key facts

Study ID

NCT01434667

Run by

Brigham and Women's Hospital

People needed

146

Starts

2010-01-01

Expected to finish

2014-07-01

Last updated by the study team

2018-10-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Individuals (55-90 years old) with Mild Cognitive Impairment (amnestic-MCI as defined by the Petersen criteria)
• Individuals who have a close friend, relative or spouse (18+) willing to be a study partner. Study partners attend each study visit with the participant and also complete surveys and interviews.

You may not qualify if…

• Individuals with current, untreated anxiety or depression
• Individuals who do not meet the criteria for amnestic-MCI
• Individuals who have the diagnosis of dementia or Alzheimer's disease
• Individuals not fluent in English
• Individuals who do not have a study partner

Where it is running

• Howard University — Washington D.C., District of Columbia, United States
• University of Michigan — Ann Arbor, Michigan, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.